|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Sector | Acquiring Party | Transferring Party |
|---|---|---|
| Biopharmaceuticals | Bayer AG | Schering AG |
| The white-knight offer (countering German Merck KGaA's bid) grows Bayer's pharmaceutical specialty product business (its primary growth more... | ||
| Biopharmaceuticals | Cambrex Corporation (NYSE: CBM) | Cutanogen Corporation |
| Cutanogen's PermaDerm cultured skin complements OrCel(R), a wound healing product from Ortec International, which Cambrex expects to market upon more... | ||
| Biopharmaceuticals | Cardinal Health, Inc (NYSE: CAH) | ParMed Pharmaceuticals, Inc. |
| Adds telemarketing resources to Cardinal and streamlines Alpharma in respect of its core competencies. Deal price $40.1m in more... | ||
| Biopharmaceuticals | China-Biotics, Inc. (OTCBB:OTRS) | Sinosmart Group Inc. |
| Enables China-Bioteics to further penetrate the Chinese probiotics marketplace and capitalize on the rapidly growing demand for domestically more... | ||
| Biopharmaceuticals | Dr. Reddy's Laboratories (NYSE: RDY ) | Betapharm Group |
| Boosts Dr. Reddy's presence in Europe and increases company revenues by $200m (2.85X). Deal price -- more... | ||
| Biopharmaceuticals | Dynavax Technologies (NASDAQ:DVAX) | Rhein Biotech GmbH |
| Dyavax gains ownership of a European Union (EU) GMP-certified vaccine manufacturing facility, control over the production of antigens to support more... | ||
| Biopharmaceuticals | Healthpoint, LTD. | BioSpecifics Technologies Corp. (BSTC.PK) |
| Adds to Healthpoint's topical product portfolio and permits BioSpecifics to focus on its core collagenase product development Deal terms -- $8m more... | ||
| Biopharmaceuticals | Johnson & Johnson (NYSE:JNJ) | ColBar LifeScience |
| J&J accesses two promising ColBar collagen products in fast growing artificial tissue segments: one for encouraging bone growth in the jaw for more... | ||
| Biopharmaceuticals | Pharmos Corporation (Nasdaq: PARS) | Vela Pharmaceutical, Inc. |
| Creates a combined drug development company focused primarily on diseases of the nervous system and autoimmune disorders. Deal value about $29.7m -- more... | ||
| Biopharmaceuticals | Ranbaxy Laboratories Limited | The unbranded generic business of Italy-based Allen S.p.A, a division of GlaxoSmithKline |
| "Fast tracks" Ranbaxy’s growth plans in Italy; complementary product portfolios and pipelines. The Italian generic market is one of more... | ||
| Biopharmaceuticals | Ranbaxy Laboratories Limited | Terapia S.A. |
| Provides major step for expanding Ranbaxy's European operations, with a broad product portfolio and deep pipeline. Ranbaxy will provide Terapia more... | ||
| Data Management/ Healthcare IT | Allscripts LLC | A4 Health Systems |
| Adds an established leader with a strong product offering and robust sales channel in two significant and underserved market segments - small, more... | ||
| Data Management/ Healthcare IT | Aptuit, Inc. | InfoPro Solutions Inc. |
| Enables Aptuit to leverage InfoPro Solutions' expertise to deploy a global, multi-customer, multi-site platform to enable clients to track drug more... | ||
| Data Management/ Healthcare IT | Decision Resources, Inc. | Millennium Research Group |
| Significantly expands Decision Resources' breadth of research services to include comprehensive coverage of medical devices. Terms not more... | ||
| Data Management/ Healthcare IT | GE Healthcare (GE) | IDX Systems Corporation (IDX) |
| Expands the offerings of GE Healthcare Information Technologies, creating a comprehensive suite of clinical, imaging, administration, and electronic more... | ||
| Data Management/ Healthcare IT | Misys Healthcare Systems | Payerpath Inc. |
| Synergizes with Misys' electronic Deal clearinghouse operations. Deal value more... | ||
| Data Management/ Healthcare IT | Per-Se Technologies, Inc. | The physician, hospital and retail pharmacy businesses of NDC Health Corp. |
| Per-Se pays $665m for the acquired businesses, which synergize with and expand Per-Se's existing data management offerings. Separately, NDC sold more... | ||
| Diagnostics | AmeriPath, Inc. | Specialty Laboratories, Inc. |
| Provides complementary services while broadening AmeriPath's base and expanding its geographic presence. Deal price more... | ||
| Diagnostics | Becton, Dickinson and Company | GeneOhm Sciences Inc. |
| Provides BD with expanded entry into the emerging healthcare-associated infections (HAI) market. A natural complement to BD's core strengths in more... | ||
| Diagnostics | Fisher Scientific International Inc. (NYSE: FSH) | Athena Diagnostics, Inc. |
| Deepens Fisher's portfolio of proprietary genetic and other markers; enhances its capabilities in personalized molecular diagnostics. Purchase more... | ||
| Diagnostics | Fisher Scientific International Inc. (NYSE: FSH) | Nanogen, Inc. (Nasdaq: NGEN) |
| Fisher and Nanogen will collaborate to expand the use of the proprietary markers and tests of Athena Diagnostics, Inc., which Fisher announced it was more... | ||
| Diagnostics | Inverness Medical Innovations, Inc. (AMEX: IMA) | The lateral flow immunoassay diagnostic products ACON Laboratories, Inc. |
| The deal settles Inverness' patent infringement claims against ACON and fortifies Inverness' position in pregnancy and fertility testing more... | ||
| Diagnostics | Inverness Medical Innovations, Inc. (AMEX: IMA) | Clondiag Chip |
| Expands Inverness' patent portfolio with nucleic acid probes and immunological tests for rapid point-of-care diagnostics. Inverness acquires more... | ||
| Diagnostics | MedMira (NASDAQ: MMIRF) | SensorChem International |
| Expands MedMira's product portfolio. Deal price -- more... | ||
| Diagnostics | Nanogen, Inc. | The rapid cardiac immunoassay test business of Spectral Diagnostics, Inc. |
| Accelerates Nanogen's growth strategy to become a leading advanced diagnostics company; complements Nanogen's Congestive Heart failure test. more... | ||
| Diagnostics | OncoVista Inc. | AdnaGen |
| AdnaGen's proprietary technology improves OncoVista's ability to select patients to respond to its targeted therapies in clinical trials. more... | ||
| Diagnostics | PerkinElmer, Inc. (NYSE: PKI) | The proprietary proteomics technology of Agilix Corporation |
| Brings quantitative proteomics to PerkinElmer customers in drug discovery and proteomics researc; enhances the utility of mass spectrometry, a more... | ||
| Diagnostics | Serologicals Corporation (NASDAQ: SERO) | LINCO Research Inc. |
| Strengthens Serological's Luminex-based Multiplexing (multiple reaction product) portfolio and enables it to address the metabolic disease more... | ||
| Diagnostics | SunTech Medical Group Limited | Oakfield Instruments Limited |
| Furthers SunTech's plans to grow into a focused medical diagnostics business.The financial investment and managerial support will enable Oakfield more... | ||
| Diagnostics | Varian, Inc. (VARI) | IonSpec Corporation |
| Increases Varian's participation in faster growing life science applications, in particular in the study of proteins, nucleic acids and drug more... | ||
| Distribution | AmerisourceBergen Corporation (NYSE:ABC) | Asenda Pharmaceutical Supplies Ltd. |
| Provides for a logical expansion of ABC's pharmaceutical distribution business in the Western Canadian provinces and continues its strategic more... | ||
| Distribution | McKesson Corporation (NYSE:MCK) | Sterling Medical Services, LLC |
| Sterling's direct-to-patient distribution to homecare patients with chronic illnesses complements McKesson's growing homecare footprint. more... | ||
| Medical Devices | Allergan, Inc. | Inamed Corporation |
| In this $3.4 billion proposal (countering a lower one by Medici Pharmaceutical Corp.) Allergan (maker of BOTOX) seeks to broaden its portfolio of more... | ||
| Medical Devices | Angiotech Pharmaceuticals, Inc. | American Medical Instruments Holdings, Inc. |
| Diversifies Angiotech's revenue base and provides manufacturing, marketing and sales capabilities in a several therapeutic areas. AMI was formed more... | ||
| Medical Devices | Cyberkinetics Neurotechnology Systems, Inc. (CYKN) | Andara Life Science Inc. |
| Adds a potentially profitable neurotechnology product line, which is subject to regulatory approval. Deal value $4.5m in more... | ||
| Medical Devices | DePuy Orthopaedics, Inc. | Hand Innovations LLC |
| Provides DePuy with leading technology in the plating business, a fast growing and under-penetrated extremities segment. DePuy's worldwide sales more... | ||
| Medical Devices | Encore Medical Corporation (Nasdaq: ENMC) | Compex Technologies, Inc. |
| Creates a stronger orthopedic products company that will combine leading electrical stimulation pain management and rehabilitation companies -- more... | ||
| Medical Devices | Integra Life Sciences Holding Corporation (IART) | Tyco's Radionics Division |
| Increases Integra's global neurosurgery offerings, adding ultrasonic aspirators and stereotactic head frames, and permits entry into the more... | ||
| Medical Devices | Johnson & Johnson (NYSE:JNJ) | Animas Corporation (Nasdaq: PUMP) |
| Fits with the J&J Lifescan unit, which makes glucose monitoring systems, and allows J&J to offer more comprehensive disease management more... | ||
| Medical Devices | Kyphon Inc. (Nasdaq: KYPH) | InnoSpine, Inc. |
| Extends Kyphon's spinal treatment solutions by adding a novel diagnostic method known as Functional Anesthetic Discography (FAD), which involves more... | ||
| Medical Devices | Moog Inc. (NYSE: MOG.A) | ZEVEX International, Inc. (Nasdaq: ZVXI) |
| Expands Moog's participation in the medical device (pump) market, adding to the 06 acquisitions of Curlin Medical and McKinley Medical. more... | ||
| Medical Devices | Ossur hf. (ICEX: OSSR) | Innovation Sports, Inc. |
| The acquisition of Innovation Sports follows Ossur's July 2005 acquisition of Royce Medical in U.S., and the December 2005 acquisition of IMP more... | ||
| Medical Devices | Plethora Solutions Holdings plc (AIM:PLE) | Timm Medical Technologies, Inc. |
| Synergizes with Plethora's urologic pharmaceutical business and adds a drug free therapy. Divestiture permits Endocare to focus on tissue and more... | ||
| Medical Devices | St. Jude Medical, Inc. (NYSE:STJ | Savacor, Inc. |
| Savacor's small implantable sensor, in clinical trials, measures left atrial pressure and body temperature to help physicians detect and manage more... | ||
| Medical Devices | Terumo Corporation | MicroVention, Inc. |
| Enables Terumo to expand into the growing worldwide market for the endovascular treatment of cerebral aneurysms. Terms not more... | ||
| Medical Devices | Zimmer Holdings, Inc. (NYSE: ZMH) | MedTech's intellectual property for BRIGIT™ device |
| Strengthens Zimmer's ability to aid surgeons' accuracy and efficiency. Terms not more... | ||
| Medical Services | BioScrip, Inc. (NASDAQ: BIOS) | Intravenous Therapy Services (ITS) |
| Enhances BioScrip's ability to service infusion patients nationally. Deal price is $13m cash, plus potential earn-outs. ITS' revenue is more... | ||
| Medical Services | Covalent Group, Inc.,(NASDAQ: CVGR) | Remedium Oy |
| Upon closing, combined company will be named Encorium BioSolutions Inc. and will enable its complex clinical trials and patient registries to expand more... | ||
| Medical Services | DSI Holding Company | Fresenius Medical Holdings, Inc. and Renal Care Group |
| Funded by Centre Partners, a private equity firm, DSI is acquiring 100 dialyses clinics being divested as part of the Fresenius-Renal Care merger. more... | ||
| Medical Services | Gentiva Health Services, Inc. (NASDAQ: GTIV) | The Healthfield Group, Inc. |
| Extends Gentiva's geographic reach in the southeast, with Healthfied's 130 locations. Deal value more... | ||
| Medical Services | Global Healthcare Exchange, LLC (GHX) | Neoforma, Inc.(NEOF) |
| The combined company will offer supply chain products and services which improve efficiencies for both providers and suppliers. Neoforma has not more... | ||
| Medical Services | Grifols | PlasmaCare, Inc. |
| PlasmaCare's 15 plasma collection centers from PlasmaCare, located in the Mid-West and the South, will be added to the 50 plasma collection more... | ||
| Medical Services | Matria Healthcare, Inc. (Nasdaq: MATR) | CorSolutions Medical, Inc. |
| Expands Matria's offerings and organization to cover disease management and related areas: wellness, productivity, behavioral health, physician more... | ||
| Medical Services | National Renal Institutes, Inc. | 100 dialysis clinics of Fresenius Medical Care AG & Co. KGaA |
| The divestiture is part of the antitrust requirements appurtenant to the merger of Fresenius and and Renal Care Group, Inc. Purchase price -- $450m more... | ||
| Medical Services | Nationwide Mutual Insurance Company | FutureHealth Corporation |
| Expands Nationwide's absence and disability management offerings, as well as enabling Nationwide to offer FutureHealth's wellness and other more... | ||
| Medical Services | Nuance Communications, Inc. (NUAN) | Dictaphone Corporation |
| Accelerates Nuance's strategy to automate medical transcription. Expands Nuance's product portfolio and market reach (installed base of over more... | ||
| Medical Services | Ventiv Health Inc. (VTIV) | Synergos, Inc. |
| Strengthens Ventiv's presence in the biotech, medical device and emerging pharmaceutical markets, adding clinical trial monitoring, regulatory more... | ||
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. | ||